Related Experiment Video
Updated: Feb 3, 2026
A Postoperative Evaluation Guideline for Computer-Assisted Reconstruction of the Mandible
Published on: January 28, 2020
[New guideline on hypertension sickens society]
1Radboudumc, afd. Eerstelijnsgeneeskunde, Nijmegen.
Insights
The new hypertension guideline in the USA may lead to over-medicalization. While it aims to reduce cardiovascular risks, the societal and economic costs of this aggressive treatment approach require careful consideration.
Area of Science:
- Cardiology
- Public Health Policy
Background:
- The recent American Heart Association (AHA) Guideline for Hypertension Management in the USA has sparked debate.
- The guideline recommends a stricter blood pressure definition (130/80 mmHg) and treatment targets below 140/90 mmHg for a larger patient group.
Purpose of the Study:
- To critically evaluate the implications of the new AHA hypertension guideline.
- To assess the potential for societal medicalization and associated costs beyond cardiovascular risk reduction.
Main Methods:
- Review of existing evidence supporting the AHA guideline.
- Analysis of the cost-effectiveness and broader societal impact of implementing the new definition and treatment targets.
Main Results:
- The guideline's evidence primarily focuses on reducing cardiovascular disease and mortality.
- The potential for widespread medicalization and its associated economic and societal costs are not fully addressed.
Conclusions:
- The stricter hypertension definition and treatment recommendations may lead to over-medicalization.
- A comprehensive assessment of costs, including societal and economic factors, is crucial when evaluating hypertension management guidelines.
Abstract:
The introduction in the USA of the new AHA Guideline on management of Hypertension has fuelled controversy on the optimal definition and treatment of hypertension. A more strict definition (130/80 mmHg) and the advice to treat the major part of the hypertensive population well below 140/90 mmHg is a recipe for medicalisation of society. Advocates of the guideline emphasise the growing body of evidence to support more aggressive treatment. This evidence however seems to focus merely on the reduction of risk on cardiovascular disease or death. It does not, however, take into account at what costs. These costs are not limited to actual cost-effectiveness of implementation of the new guideline but stretch far beyond to involve also the actual and societal costs of medicalisation.
Related Concept Videos
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:30Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
01:23Guidelines for Sketching a Curve
01:26Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
01:06Legal Guidelines for Documentation
01:28Hypertension I: Introduction